The worldwide scramble to prevent the next oxygen shortage politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
Really good news : Federal defense bill could move UNMC NExT project forward
Multi-billion dollar expansion would bring federal disaster response facility to the campus Share Updated: 10:29 PM CST Jan 17, 2021
Multi-billion dollar expansion would bring federal disaster response facility to the campus Share Updated: 10:29 PM CST Jan 17, 2021
Hide Transcript
Show Transcript FORWARD. ALEXANDRA: IMAGINE THIS CORNER OF THE UNMC CAMPUS TRANSFORMED, TWO AND A HALF MILLION SQUARE FEET OF NEW CONSTRUCTION RISING ABOVE FARNAM AND SADDLE CREEK. IT IS A TRANSFORMATION FOR OUR REGION, FOR OUR STATE. ALEXANDRA: THE NEXT PROJECT IS MEANT TO BE PART OF NETWORK OF FACILITIES ACROSS THE COUNTRY EQUIPPED FOR LARGE SCALE DISASTER RESPONSE. UNMC CHANCELLOR DR. JEFFREY GOLD SAYS THAT’S EVERYTHING FROM HURRICANES AND TORNADOES TO CHEMICAL SPILLS, NUCLEAR ACCIDENTS AND INFECTIOUS DISEASES. SOMEWHERE BETWEEN FIVE AND 15 DEDICATED CENTERS THAT COULD EXPAND AND CO
Tags »
In a randomized, controlled trial of more than 1,000 adults hospitalized with COVID-19 pneumonia, treatment with the anti-inflammatory drug baricitinib resulted in faster recovery and a greater likelihood of clinical improvement, when combined with the antiviral drug remdesivir.
The results of the international ACTT-2 (Adaptive COVID-19 Treatment Trial), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, were published Friday Dec. 11 in the
Baricitinib was originally developed by Eli Lilly and Company for rheumatoid arthritis and was FDA-approved for that indication in 2017. The drug, part of a class of drugs that inhibits JAK enzymes, received an emergency use authorization for COVID-19 treatment in November 2020, based upon the ACTT-2 results.